Colleen Delaney

Director/Board Member at VICAPSYS LIFE SCIENCES, INC.

Net worth: - $ as of 31/07/2026

59 year

94 connections

Health Technology

Consumer Services

Commercial Services

Profile

Colleen Delaney is the founder of Nohla Therapeutics, Inc., Deverra Therapeutics, Inc. Current positions include Director at American Society for Blood & Marrow Transplantation, Director at Vicapsys Life Sciences, Inc. since 2022, and Clinical Professor at the University of Washington.
Former positions include Professor at Fred Hutchinson Cancer Research Center, Professor at Fred Hutchinson Cancer Center, and Chief Scientific & Medical Officer at Coeptis Therapeutics Holdings, Inc. from 2023 to 2025.
Education includes graduate studies at the University of Oxford and a doctorate from Harvard Medical School conferred in 1996.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
-.--%	26/03/2025	0 ( -.--% )	- $	31/07/2026

Colleen Delaney active positions

Companies	Position	Start
VICAPSYS LIFE SCIENCES, INC.	Director/Board Member	22/09/2022
American Society for Blood & Marrow Transplantation American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs.	Director/Board Member	-
Deverra Therapeutics, Inc. Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies	Founder	-
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Colleen Delaney

Former positions of Colleen Delaney

Companies	Position	End
COEPTIS THERAPEUTICS	Chief Tech/Sci/R&D Officer	24/03/2025
Fred Hutchinson Cancer Center Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer treatment center	Corporate Officer/Principal	-
Fred Hutchinson Cancer Research Center Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services	Corporate Officer/Principal	-
Nohla Therapeutics, Inc. Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders	Founder	-

See the detail of Colleen Delaney's experience

Training of Colleen Delaney

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Colleen Delaney's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fred Hutchinson Cancer Research Center Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services	Commercial Services
American Society for Blood & Marrow Transplantation American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs.
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops transplantation therapies and encapsulated product candidates	Health Technology
Fred Hutchinson Cancer Center Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer treatment center	Health Services
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nohla Therapeutics, Inc. Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders	Health Technology
Deverra Therapeutics, Inc. Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies	Health Technology
Coeptis Therapeutics Holdings, Inc. Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer	Health Technology